About Sense biodetection ltd
Sense Biodetection Ltd: Revolutionizing Healthcare Diagnostics
Sense Biodetection Ltd is a leading healthcare diagnostics company that is transforming the way we diagnose diseases. The company has developed innovative technology that allows for instrument-free, rapid and accurate detection of pathogens, making it possible to diagnose diseases in real-time.
The company's mission is to redefine diagnostics by providing fast, reliable and affordable testing solutions that can be used anywhere. Sense Biodetection's technology has the potential to revolutionize healthcare by enabling early detection of diseases and reducing the spread of infections.
Sense Biodetection's innovative platform uses a combination of molecular biology techniques and nanotechnology to detect pathogens in samples such as blood, saliva or urine. The technology works by amplifying DNA or RNA sequences from the pathogen using a process called loop-mediated isothermal amplification (LAMP). This amplified DNA or RNA sequence then binds with gold nanoparticles which change color when exposed to light. This color change indicates the presence of the pathogen in the sample.
One of Sense Biodetection's key advantages over traditional diagnostic methods is its speed. The platform can detect pathogens within minutes, compared to hours or even days for traditional methods such as PCR (polymerase chain reaction) tests. This rapid turnaround time means that patients can receive treatment faster, reducing their risk of complications and improving their chances of recovery.
Another advantage of Sense Biodetection's technology is its mobility. The platform does not require any specialized equipment or infrastructure, making it ideal for use in remote locations where access to laboratory facilities may be limited. This makes it possible for healthcare providers to quickly diagnose diseases on-site without having to transport samples back and forth between clinics and laboratories.
Sense Biodetection's technology also offers high accuracy rates compared with other diagnostic methods currently available on the market. In clinical trials conducted by independent laboratories, Sense Biodetection achieved sensitivity rates ranging from 90% - 100% and specificity rates ranging from 95% - 100%. These results demonstrate the platform's ability to accurately detect pathogens in a variety of sample types.
Sense Biodetection's technology has a wide range of potential applications in healthcare, including infectious disease diagnosis, cancer screening, and monitoring of chronic diseases such as diabetes. The company is currently focused on developing tests for respiratory infections such as COVID-19 and influenza, which have become major public health concerns in recent years.
In addition to its innovative technology, Sense Biodetection is committed to sustainability and reducing its environmental impact. The company uses biodegradable materials wherever possible and has implemented recycling programs for its products.
Overall, Sense Biodetection Ltd is a game-changer in the field of healthcare diagnostics. Its innovative technology offers fast, accurate and affordable testing solutions that have the potential to transform the way we diagnose diseases. With its commitment to sustainability and improving global health outcomes, Sense Biodetection is poised to make a significant impact on the world stage.